What is Alogliptin?

Category: Prescription Drugs

Most popular types: Nesina


Alogliptin is a medication to treat adults with Type 2 diabetes. It is in a class of medications called dipeptidyl peptidase-4 (DPP-4) inhibitors and works by increasing the amount of insulin in the body to control blood sugar.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 0
Moderate 0
Mild 0
None 4

Commonly reported side effects and conditions associated with Alogliptin

Side effect Patients Percentage


Based on patients currently taking Alogliptin

Dosage Patients Percentage
25 mg daily 3
12.5 mg daily 1

Why patients stopped taking Alogliptin

Multiple reasons could be selected

Reason Patients Percentage
Change in health plan coverage 1
See 1 patient who's stopped taking Alogliptin


Currently taking Alogliptin

Duration Patients Percentage
1 - 6 months 2
6 months - 1 year 2

Stopped taking Alogliptin

Duration Patients Percentage
1 - 6 months 1
Adherence Evaluations Percentage
Always 3
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden Evaluations Percentage
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 4
Cost per month
Cost per month Evaluations Percentage
$200+ 0
$100-199 0
$50-99 0
$25-49 0
< $25 1
Not specified 3

What people switch to and from

Patients started taking Alogliptin after stopping:

Treatment Patients Percentage
Canagliflozin (Invokana) 1
Empaglifozin (Jardiance) 1
Insulin NPH (Novolin N) 1
Sitagliptin (Januvia) 1
Sitagliptin-metformin (Janumet) 1

Patients stopped taking Alogliptin and switched to:

Treatment Patients Percentage
Linagliptin (Tradjenta) 1
Sitagliptin (Januvia) 1
Last updated:
There are no evaluations for Alogliptin.